Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58,874,321
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
39,704,878
-
Shares change
-
+3,360,965
-
Total reported value, excl. options
-
$555,846,956
-
Value change
-
+$44,096,425
-
Put/Call ratio
-
157%
-
Number of buys
-
66
-
Number of sells
-
-71
-
Price
-
$14.00
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2017
165 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q1 2017.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,704,878 shares
of 58,874,321 outstanding shares and own 67% of the company stock.
Largest 10 shareholders include Palo Alto Investors, LLC (4,203,270 shares), BlackRock Inc. (3,853,200 shares), VANGUARD GROUP INC (2,494,347 shares), Point72 Asset Management, L.P. (2,484,500 shares), DEERFIELD MANAGEMENT CO (2,299,046 shares), GREAT POINT PARTNERS LLC (2,232,238 shares), ARMISTICE CAPITAL, LLC (1,608,000 shares), FMR LLC (1,601,171 shares), MORGAN STANLEY (1,594,496 shares), and STATE STREET CORP (1,572,186 shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.